NAICS 62221 - Psychiatric and Substance Abuse Hospitals
This industry comprises establishments known and licensed as psychiatric and substance abuse hospitals primarily engaged in providing diagnostic, medical treatment, and monitoring services for inpatients who suffer from mental illness or substance abuse disorders. The treatment often requires an extended stay in the hospital. These establishments maintain inpatient beds and provide patients with food services that meet their nutritional requirements. They have an organized staff of physicians and other medical staff to provide patient care services. Psychiatric, psychological, and social work services are available at the facility. These hospitals usually provide other services, such as outpatient services, clinical laboratory services, diagnostic X-ray services, and electroencephalograph services.
Industry trends:
The psychiatric and substance abuse hospital industry, classified under NAICS 62221, is undergoing significant qualitative trends that are reshaping its landscape. One prominent trend is the increasing integration of telehealth services. This shift has been accelerated by the COVID-19 pandemic, leading to a growing acceptance and reliance on virtual consultations and remote patient monitoring. Telehealth's convenience and accessibility make it a valuable tool for ongoing psychiatric and substance abuse treatment.
There is also a heightened focus on holistic and personalized care approaches. Hospitals are incorporating comprehensive treatment plans that address not only the psychiatric and substance abuse issues but also the associated social, psychological, and emotional factors. This trend is driven by the recognition that multi-dimensional care significantly improves patient outcomes.
Additionally, there is a growing emphasis on the use of data analytics and artificial intelligence (AI). These technologies are being utilized to enhance patient care through predictive analytics, personalized treatment recommendations, and improved patient management systems. AI, for example, can help in identifying early indicators of relapse in substance abuse patients, allowing for timely intervention.
Looking to the near future, these trends are expected to continue and evolve. Regulatory support for telehealth services may increase, further entrenching its role in psychiatric and substance abuse care. Investments in AI and data analytics tools are also likely to grow, with a focus on improving precision medicine. Lastly, holistic care models may become a standard practice as the industry recognizes the necessity of addressing the full spectrum of factors impacting mental health and substance abuse recovery.
This industry is comprised of:
Alcoholism rehabilitation hospitals
Children's hospitals, psychiatric or substance abuse
Detoxification hospitals
Drug addiction rehabilitation hospitals
Hospitals for alcoholics
Hospitals, addiction
Hospitals, mental (except mental retardation)
Hospitals, psychiatric (except convalescent)
Hospitals, psychiatric pediatric
Hospitals, substance abuse
Mental (except mental retardation) hospitals
Mental health hospitals
Psychiatric hospitals (except convalescent)
Rehabilitation hospitals, alcoholism and drug addiction
This report includes the ability to segment your Industry by:
- Region
- Employees
- Net Sales
- Company Age
- Total Assets
- Ownership Type
With iCFO You Get
What Is iCFO?
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Sound Business Analysis
Answers come easily with iCFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine what if scenarios and P&L impact of reducing costs or adding revenue.
Your Business’ Health In Minutes
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.